Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Ethics in Psychiatric Research: Issues and Recommendations.

Jain S, Kuppili PP, Pattanayak RD, Sagar R.

Indian J Psychol Med. 2017 Sep-Oct;39(5):558-565. doi: 10.4103/IJPSYM.IJPSYM_131_17. Review.

2.

Moral Stress and Job Burnout Among Frontline Staff Conducting Clinical Research on Affective and Anxiety Disorders.

Fried AL, Fisher CB.

Prof Psychol Res Pr. 2016 Jun;47(3):171-180. doi: 10.1037/pro0000060.

3.

The effect of depression on the decision to join a clinical trial.

Leykin Y, Dunn LB, Muñoz RF.

J Consult Clin Psychol. 2017 Jul;85(7):751-756. doi: 10.1037/ccp0000212. Epub 2017 Apr 10.

PMID:
28394169
4.
5.

Ethical Issues in Deep Brain Stimulation Research for Treatment-Resistant Depression: Focus on Risk and Consent.

Dunn LB, Holtzheimer PE, Hoop JG, Mayberg HS, Appelbaum PS.

AJOB Neurosci. 2011;2(1):29-36.

6.

Participants' Perceptions of Deep Brain Stimulation Research for Treatment-Resistant Depression: Risks, Benefits, and Therapeutic Misconception.

Leykin Y, Christopher PP, Holtzheimer PE, Appelbaum PS, Mayberg HS, Lisanby SH, Dunn LB.

AJOB Prim Res. 2011 Oct;2(4):33-41.

7.

Informed consent in the psychosis prodrome: ethical, procedural and cultural considerations.

Morris SE, Heinssen RK.

Philos Ethics Humanit Med. 2014 Nov 18;9:19. doi: 10.1186/1747-5341-9-19. Review.

8.
9.

Ethics in Psychiatric Research: A Review of 25 Years of NIH-funded Empirical Research Projects.

Dubois J, Bante H, Hadley WB.

AJOB Prim Res. 2011 Jan 1;2(4):5-17. Epub 2011 Dec 6.

10.

Screening for understanding of research in the inpatient psychiatry setting.

Hickman NJ, Prochaska JJ, Dunn LB.

J Empir Res Hum Res Ethics. 2011 Sep;6(3):65-72. doi: 10.1525/jer.2011.6.3.65.

11.

Longitudinal consent-related abilities among research participants with schizophrenia: results from the CATIE study.

Stroup TS, Appelbaum PS, Gu H, Hays S, Swartz MS, Keefe RS, Kim SY, Manschreck TC, Boshes RA, McEvoy JP, Lieberman JA.

Schizophr Res. 2011 Aug;130(1-3):47-52. doi: 10.1016/j.schres.2011.04.012. Epub 2011 May 10.

12.

Capacity to make medical treatment decisions in multiple sclerosis: a potentially remediable deficit.

Basso MR, Candilis PJ, Johnson J, Ghormley C, Combs DR, Ward T.

J Clin Exp Neuropsychol. 2010 Dec;32(10):1050-61. doi: 10.1080/13803391003683062.

13.

Research ethics issues in geriatric psychiatry.

Dunn LB, Misra S.

Psychiatr Clin North Am. 2009 Jun;32(2):395-411. doi: 10.1016/j.psc.2009.03.007. Review.

14.

Worth the risk? Relationship of incentives to risk and benefit perceptions and willingness to participate in schizophrenia research.

Dunn LB, Kim DS, Fellows IE, Palmer BW.

Schizophr Bull. 2009 Jul;35(4):730-7. doi: 10.1093/schbul/sbn003. Epub 2008 Feb 14.

15.

A direct comparison of research decision-making capacity: schizophrenia/schizoaffective, medically ill, and non-ill subjects.

Candilis PJ, Fletcher KE, Geppert CM, Lidz CW, Appelbaum PS.

Schizophr Res. 2008 Feb;99(1-3):350-8. doi: 10.1016/j.schres.2007.11.022.

16.
17.

Ethics of medication-free research in schizophrenia.

Chen DT, Moreno JD.

Schizophr Bull. 2006 Apr;32(2):307-9. Epub 2006 Feb 8. No abstract available.

Supplemental Content

Support Center